Studies in hepatocellular carcinoma revealed that CASC2 prohibited mesenchymal–epithelial transition progression and exerted anti-metastatic effect via CASC2/mirR-396/FBXW7 axis [9]. Here, CASC2 is linked to hepatocellular carcinoma.